INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 42h ago
House PTR2h ago
SEC 13F2h ago
Robinhood Chain2h ago

Results

76,380 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
7
EP
Enguent Jean-PierreVice President, R&DSS
LAESSEALSQ Corp
Option exercise · 10b5-1 plan
M—
15.0K sh
Jun 1, 2026Jun 3, 2026
Page 873 of 1910
← PrevNext →
traded Jun 1, 2026
+2d
SEC Form 4

Evidence

7
NA
Nithrakashyap ArvindDirector, Chief Technology Officer
RBRKRubrik, Inc.
Open-market sale · 10b5-1 plan
SELL$331K
4,155 sh
Jun 1, 2026Jun 3, 2026
traded Jun 1, 2026
+2dSEC Form 4

Evidence

7
MA
Misra AmitabhChief Technology Officer
CXMSprinklr, Inc.
Open-market sale · 10b5-1 plan
SELL$267K
45.1K sh
Jun 1, 2026Jun 3, 2026
traded Jun 1, 2026
+2dSEC Form 4

Evidence

7
WM
Wittmann MichaelChief Operating Officer
INDIindie Semiconductor, Inc.
Option exercise · 10b5-1 plan
M—
37.5K sh
Jun 1, 2026Jun 3, 2026
traded Jun 1, 2026
+2dSEC Form 4

Evidence

6
VS
Verma ShivChief Financial Officer
HOODRobinhood Markets, Inc.
Option exercise
M—
23.6K sh
Jun 1, 2026Jun 3, 2026
traded Jun 1, 2026
+2dSEC Form 4

Evidence

6
VS
Verma ShivChief Financial Officer
HOODRobinhood Markets, Inc.
Option exercise
M—
9,692 sh
Jun 1, 2026Jun 3, 2026
traded Jun 1, 2026
+2dSEC Form 4

Evidence

6
MS
Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS
NTRANatera, Inc.
Open-market sale · 10b5-1 plan
SELL$126K
572 sh
Jun 1, 2026Jun 3, 2026
traded Jun 1, 2026
+2dSEC Form 4

Evidence

6
MS
Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS
NTRANatera, Inc.
Open-market sale · 10b5-1 plan
SELL$90K
413 sh
Jun 1, 2026Jun 3, 2026
traded Jun 1, 2026
+2dSEC Form 4

Evidence

5
RM
Rodrigues Fernando M.President of BetterHelp
TDOCTeladoc Health, Inc.
Option exercise
M—
5,491 sh
Jun 1, 2026Jun 3, 2026
traded Jun 1, 2026
+2dSEC Form 4

Evidence

5
MP
Melwani PraveerCFO and Treasurer
FIGFigma, Inc.
Tax withholding
F$179K
7,038 sh
Jun 1, 2026Jun 3, 2026
traded Jun 1, 2026
+2dSEC Form 4

Evidence

5
MB
Mulligan BrendanGeneral Counsel and Secretary
FIGFigma, Inc.
Tax withholding
F$241K
9,435 sh
Jun 1, 2026Jun 3, 2026
traded Jun 1, 2026
+2dSEC Form 4

Evidence

5
KJ
Kim Peter Sung-JipSVP & GM Industrial Business
LFUSLITTELFUSE INC /DE
Option exercise
M—
3,045 sh
Jun 2, 2026Jun 3, 2026
traded Jun 2, 2026
+1dSEC Form 4

Evidence

5
CA
Calhoun Kirk A.Director
SBSISOUTHSIDE BANCSHARES INC
Grant or award
A—
19 sh
Jun 1, 2026Jun 3, 2026
traded Jun 1, 2026
+2dSEC Form 4

Evidence

5
RK
Rasmussen KrisChief Technology Officer
FIGFigma, Inc.
Tax withholding
F$220K
8,641 sh
Jun 1, 2026Jun 3, 2026
traded Jun 1, 2026
+2dSEC Form 4

Evidence

5
CT
Chuang Patrick T.Senior VP, Memory Design
GSITGSI TECHNOLOGY INC
Option exercise
M—
40.0K sh
Jun 1, 2026Jun 3, 2026
traded Jun 1, 2026
+2dSEC Form 4

Evidence

5
VS
Voskanian ShauntChief Revenue Officer
FIGFigma, Inc.
Tax withholding
F$206K
8,081 sh
Jun 1, 2026Jun 3, 2026
traded Jun 1, 2026
+2dSEC Form 4

Evidence

5
KJ
Kim Peter Sung-JipSVP & GM Industrial Business
LFUSLITTELFUSE INC /DE
Option exercise
M—
2,486 sh
Jun 2, 2026Jun 3, 2026
traded Jun 2, 2026
+1dSEC Form 4

Evidence

5
KJ
Kim Peter Sung-JipSVP & GM Industrial Business
LFUSLITTELFUSE INC /DE
Option exercise
M—
1,355 sh
Jun 2, 2026Jun 3, 2026
traded Jun 2, 2026
+1dSEC Form 4

Evidence

5
SP
Sachdeva PrernaChief Accounting Officer
ALKTALKAMI TECHNOLOGY, INC.
Tax withholding
F$26K
1,370 sh
Jun 1, 2026Jun 3, 2026
traded Jun 1, 2026
+2dSEC Form 4

Evidence

5
BK
Bliss KellyPresident, U.S. Group Health
TDOCTeladoc Health, Inc.
Option exercise
M—
1,300 sh
Jun 1, 2026Jun 3, 2026
traded Jun 1, 2026
+2dSEC Form 4

Evidence

5
MI
Mecklenburg Gabriel M.I.Director, Exec. Chairman & Co-Founder
HNGEHinge Health, Inc.
Open-market sale · 10b5-1 plan
SELL$246K
4,258 sh
Jun 1, 2026Jun 3, 2026
traded Jun 1, 2026
+2dSEC Form 4

Evidence

5
KJ
Kim Peter Sung-JipSVP & GM Industrial Business
LFUSLITTELFUSE INC /DE
Option exercise
M—
3,285 sh
Jun 2, 2026Jun 3, 2026
traded Jun 2, 2026
+1dSEC Form 4

Evidence

4
NA
Nithrakashyap ArvindDirector, Chief Technology Officer
RBRKRubrik, Inc.
Open-market sale · 10b5-1 plan
SELL$157K
1,938 sh
Jun 1, 2026Jun 3, 2026
traded Jun 1, 2026
+2dSEC Form 4

Evidence

4
NA
Nithrakashyap ArvindDirector, Chief Technology Officer
RBRKRubrik, Inc.
Open-market sale · 10b5-1 plan
SELL$450K
5,655 sh
Jun 3, 2026Jun 3, 2026
traded Jun 3, 2026
+0dSEC Form 4

Evidence

4
KA
Kerdman AlinaSVP, Controller & CAO
CTSHCOGNIZANT TECHNOLOGY SOLUTIONS CORP
Option exercise · 10b5-1 plan
M—
14 sh
Jun 1, 2026Jun 3, 2026
traded Jun 1, 2026
+2dSEC Form 4

Evidence

4
NA
Nithrakashyap ArvindDirector, Chief Technology Officer
RBRKRubrik, Inc.
Open-market sale · 10b5-1 plan
SELL$821K
9,986 sh
Jun 2, 2026Jun 3, 2026
traded Jun 2, 2026
+1dSEC Form 4

Evidence

4
NA
Nithrakashyap ArvindDirector, Chief Technology Officer
RBRKRubrik, Inc.
Open-market sale · 10b5-1 plan
SELL$335K
4,246 sh
Jun 3, 2026Jun 3, 2026
traded Jun 3, 2026
+0dSEC Form 4

Evidence

3
MS
Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS
NTRANatera, Inc.
Open-market sale · 10b5-1 plan
SELL$47K
213 sh
Jun 1, 2026Jun 3, 2026
traded Jun 1, 2026
+2dSEC Form 4

Evidence

3
WM
Wittmann MichaelChief Operating Officer
INDIindie Semiconductor, Inc.
Option exercise · 10b5-1 plan
M—
37.5K sh
Jun 1, 2026Jun 3, 2026
traded Jun 1, 2026
+2dSEC Form 4

Evidence

2
CT
Chuang Patrick T.Senior VP, Memory Design
GSITGSI TECHNOLOGY INC
Option exercise
M—
40.0K sh
Jun 2, 2026Jun 3, 2026
traded Jun 2, 2026
+1dSEC Form 4

Evidence

2
KA
Kerdman AlinaSVP, Controller & CAO
CTSHCOGNIZANT TECHNOLOGY SOLUTIONS CORP
Open-market sale · 10b5-1 plan
SELL$8,236
146 sh
Jun 1, 2026Jun 3, 2026
traded Jun 1, 2026
+2dSEC Form 4

Evidence

1
NA
Nithrakashyap ArvindDirector, Chief Technology Officer
RBRKRubrik, Inc.
Open-market sale · 10b5-1 plan
SELL$23K
262 sh
Jun 1, 2026Jun 3, 2026
traded Jun 1, 2026
+2dSEC Form 4

Evidence

1
NA
Nithrakashyap ArvindDirector, Chief Technology Officer
RBRKRubrik, Inc.
Open-market sale · 10b5-1 plan
SELL$132K
1,700 sh
Jun 3, 2026Jun 3, 2026
traded Jun 3, 2026
+0dSEC Form 4

Evidence

1
NA
Nithrakashyap ArvindDirector, Chief Technology Officer
RBRKRubrik, Inc.
Open-market sale · 10b5-1 plan
SELL$69K
831 sh
Jun 2, 2026Jun 3, 2026
traded Jun 2, 2026
+1dSEC Form 4

Evidence

1
NA
Nithrakashyap ArvindDirector, Chief Technology Officer
RBRKRubrik, Inc.
Open-market sale · 10b5-1 plan
SELL$79K
1,027 sh
Jun 3, 2026Jun 3, 2026
traded Jun 3, 2026
+0dSEC Form 4

Evidence

1
NA
Nithrakashyap ArvindDirector, Chief Technology Officer
RBRKRubrik, Inc.
Open-market sale · 10b5-1 plan
SELL$149K
1,833 sh
Jun 2, 2026Jun 3, 2026
traded Jun 2, 2026
+1dSEC Form 4

Evidence

1
MI
Mecklenburg Gabriel M.I.Director, Exec. Chairman & Co-Founder
HNGEHinge Health, Inc.
Open-market sale · 10b5-1 plan
SELL$145K
2,542 sh
Jun 1, 2026Jun 3, 2026
traded Jun 1, 2026
+2dSEC Form 4

Evidence

1
MI
Mecklenburg Gabriel M.I.Director, Exec. Chairman & Co-Founder
HNGEHinge Health, Inc.
Open-market sale · 10b5-1 plan
SELL$67K
1,200 sh
Jun 1, 2026Jun 3, 2026
traded Jun 1, 2026
+2dSEC Form 4

Evidence

0
BH
Bernstein HaroldPresident, R&D & CMO
MAZEMaze Therapeutics, Inc.
Option exercise · 10b5-1 plan
M$155K
14.9K sh
Jun 1, 2026Jun 3, 2026
traded Jun 1, 2026
+2dSEC Form 4

Evidence

0
KA
Kerdman AlinaSVP, Controller & CAO
CTSHCOGNIZANT TECHNOLOGY SOLUTIONS CORP
Option exercise · 10b5-1 plan
M—
198 sh
Jun 1, 2026Jun 3, 2026
traded Jun 1, 2026
+2dSEC Form 4

Evidence